Oracle shares up 2.6% after brokerages raise price targets ahead of results on Tuesday

Oracle shares up 2.6% after brokerages raise price targets ahead of results on Tuesday

Oracle Corporation (NYSE: ORCL) saw its stock price rise by 2.6% on Friday, reaching a high of $232.77, as several brokerage firms increased their price targets for the company ahead of its earnings report scheduled for Tuesday. The stock's performance follows a series of positive analyst ratings and strategic initiatives that have bolstered investor confidence.

Global Equities Research, one of the firms that raised its price target, increased its target to $400.00 from $250.00 while maintaining an Overweight rating. This significant increase reflects the firm's belief in Oracle's long-term fundamentals and the company's strategic position in the AI sector [1].

Additionally, several other analysts have recently revised their price targets for Oracle. For instance, Goldman Sachs Group reaffirmed a neutral rating and raised its price objective to $195.00, while Morgan Stanley reaffirmed an Overweight rating. JMP Securities increased its price objective to $315.00 and gave the company a Market Outperform rating. CIBC reaffirmed a Buy rating, and Barclays reaffirmed an Overweight rating with a $221.00 price objective [2].

Oracle has been the subject of favorable analyst activity, with three analysts rating the stock with a Strong Buy rating and twenty-three issuing a Buy rating. The stock has an average rating of Moderate Buy and a consensus target price of $227.04 [2].

The company's recent earnings report showed strong performance, with earnings per share (EPS) of $1.70, beating the consensus estimate of $1.64. Revenue for the quarter was $15.90 billion, up 11.3% compared to the same quarter last year. Oracle also declared a quarterly dividend of $0.50 per share, paid on July 24th [2]. Historically, when Oracle has beaten earnings expectations, the stock has demonstrated positive momentum, with a 62.5% win rate over three days and 62.5% over 30 days, according to backtests of similar events from 2022 to the present. The maximum observed return in such scenarios was 7.91%.

Oracle's strategic initiatives, including its expanded partnership with Google Cloud and its $38 billion debt package led by JPMorgan Chase & Co. and Mitsubishi UFJ Financial Group Inc., have further solidified its market position. The company is also expanding its influence in the healthcare sector, with NYC Health + Hospitals planning to adopt Oracle Fusion Cloud Applications [1].

Institutional investors have also shown increased interest in Oracle, with several large investors increasing their holdings in the company. For example, Brighton Jones LLC lifted its position by 189.3% during the 4th quarter, while Focus Partners Wealth increased its position by 10.5% [2].

As Oracle approaches its earnings report, investors are closely watching the company's performance and the potential impact of the recent price target revisions. The stock's upward trajectory and strong analyst support suggest a positive outlook for the company, although the market's response to the earnings report will be crucial in determining Oracle's future stock performance.

References:
[1] https://www.investing.com/news/analyst-ratings/oracle-stock-price-target-raised-to-400-from-250-at-global-equities-93CH-4226985
[2] https://www.marketbeat.com/instant-alerts/oracle-nyseorcl-trading-up-2-heres-why-2025-09-05/